Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2019
May 13, 2019 at 12:12 am IST
Medigen Vaccine Biologics Corporation announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced operating loss was TWD 136.797 million compared to TWD 86.379 million a year ago. Net loss was TWD 138.602 million compared to TWD 89.956 million a year ago. Basic loss per share was TWD 0.89 compared to TWD 0.66 a year ago.